accountWASHINGTON -(Dow Jones)- A unit of King Pharmaceuticals Inc. (KG) has agreed to pay $42.5 million to settle charges that it paid doctors to promote and prescribe the firm's morphine drug Kadian, the U.S...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to DOJ:King Pharma Unit To Pay $42.5 Million To Settle Marketing Lawsuit
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account